US 10093676
Compounds useful as inhibitors of ATR kinase
granted A61PA61P35/00A61P43/00
Quick answer
US patent 10093676 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P35/00, A61P43/00